IDO2 and neoplasm: Indoleamine 2,3 dioxygenase (IDO) is mainly a tumor cell‐derived, inflammation‐induced, immunosuppressive factor (Muller et al., 2008; Uyttenhove et al., 2003) that promotes tumor progression.